STOCK TITAN

Sientra to Report Second Quarter 2023 Financial Results on August 10, 2023

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary
Sientra, Inc. will release its financial results for Q2 2023 on August 10, 2023, after the market closes. The company will host a conference call at 4:30 p.m. Eastern Time on the same day to discuss the results. Domestic callers can dial (844) 735-3763 and international callers can dial (412) 317-5711 to join the call. A live webcast of the conference call will be available on the Investor Relations section of Sientra's website.
Positive
  • None.
Negative
  • None.

IRVINE, Calif., July 27, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN)(“Sientra” or the “Company”), a medical aesthetics company developing the safest and most innovative solutions for the best aesthetic outcomes, today announced that it will release financial results for the second quarter of 2023 after the close of trading on Thursday, August 10, 2023. Sientra will host a conference call to discuss financial results the same day at 4:30 p.m. Eastern Time.  

The dial-in numbers are (844) 735-3763 for domestic callers and (412) 317-5711 for international callers.

A live webcast of the conference call will be available on the Investor Relations section of the Company's website at www.sientra.com. The webcast will be archived on the website following the completion of the call.

About Sientra

Headquartered in Irvine, California, Sientra is a medical aesthetics company focused on empowering people to change their lives through increased self-confidence and self-respect. Backed by unrivaled clinical and safety data, Sientra’s platform of products includes a comprehensive portfolio of round and shaped breast implants, the first fifth-generation breast implants approved by the FDA for sale in the United States, the ground-breaking AlloX2 breast tissue expander with patented dual-port and integral drain technology, the next-generation AlloX2Pro™, the first and only FDA-cleared MRI-compatible tissue expander, the Viality™ with AuraClens™ enhanced viability fat transfer system, the SimpliDerm Human Acellular Dermal Matrix, and BIOCORNEUM the #1 performing, preferred and recommended scar gel of plastic surgeons (*).

Sientra uses its investor relations website to publish important information about the Company, including information that may be deemed material to investors. Financial and other information about Sientra is routinely posted and is accessible on the Company’s investor relations website at www.sientra.com.

To learn more about Sientra, visit our website and follow Sientra on LinkedIn, Instagram, and Facebook.

(*) Data on file

Investor Relations Contact

Aman R. Patel, CFA
aman.patel@westwicke.com

 


FAQ

When will Sientra release its financial results for Q2 2023?

Sientra will release its financial results for Q2 2023 on August 10, 2023.

What time will the conference call to discuss the financial results be held?

The conference call to discuss the financial results will be held at 4:30 p.m. Eastern Time.

How can domestic callers join the conference call?

Domestic callers can dial (844) 735-3763 to join the conference call.

How can international callers join the conference call?

International callers can dial (412) 317-5711 to join the conference call.

Where can I find the live webcast of the conference call?

The live webcast of the conference call will be available on the Investor Relations section of Sientra's website.

Sientra, Inc.

NASDAQ:SIEN

SIEN Rankings

SIEN Latest News

SIEN Stock Data

2.08M
11.05M
9.61%
17.04%
10.94%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States
Santa Barbara

About SIEN

medical devices- plastic surgery: aesthetic and reconstructive, urology